effect suramin tumor necrosis factor interferon gamma human prostate carcinoma Suramin antiparasitic agent stimulatory effect growth factors certain cancers clinical trials antineoplastic agent patients advanced prostate carcinoma Preliminary studies suramin growth vitro human prostate carcinoma present study order effect suramin recombinant human tumor necrosis factor TNF interferon gamma combination suramin TNF gamma proliferation human hormone unresponsive prostate carcinoma cell line medium fetal calf serum FCS suramin doses microM microM microM levels achievable humans proliferation TNF concentration inhibition growth combination suramin TNF inhibition growth low dose microM suramin Interferon gamma growth combination interferon gamma suramin microM inhibition proliferation gamma results rationale clinical trials combination TNF suramin patients advanced prostate carcinoma 